OTC Markets OTCQB - Delayed Quote USD

Guided Therapeutics, Inc. (GTHP)

0.1400

0.0000

(0.00%)

At close: June 2 at 2:55:59 PM EDT

Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in China

PEACHTREE CORNERS, Ga., May 27, 2025--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received a $100,000 payment from Shandong Yaohua Medical Instrument Corporation (SMI) via its investment partners to assist in commercializing LuViva in China. The $100,000 payment is the first of several such payments that provide for an extension of GTHP’s agreement with SMI to commercialize LuViva in China upon regulatory approval in China

Business Wire 7 days ago

GTHP
0.00%
Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables

PEACHTREE CORNERS, Ga., December 10, 2024--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that it had received full payment from its Indonesian distribution partner for four LuViva devices and 1,200 single-use cervical guides. Delivery of the systems is expected to occur in the first quarter of 2025. This initial shipment of LuViva devices for the government healthcare system in Sulawesi will be utilized to identify women with cervical ca

Business Wire 5 months ago

GTHP
0.00%
Guided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in China

PEACHTREE CORNERS, Ga., October 22, 2024--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that its Chinese Partner, Shandong Yaohua Medical Instrument Corporation (SMI), has filed its application for LuViva with the Chinese National Medical Products Administration (NMPA). The application included results from 449 women tested at four leading medical institutions in China. The results of the study were above that required for a successful s

Business Wire 7 months ago

GTHP
0.00%
Guided Therapeutics’ Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites With Better Than Expected Results

PEACHTREE CORNERS, Ga., July 10, 2024--Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced today that leading physicians from four prestigious medical centers have completed their review and signed off on the study results for submission to the Chinese National Medical Products Administration (NMPA). Approximately 460 women were tested with LuViva at four leading hospitals in China. There were no adverse events reported with the use of LuViva during

Business Wire 10 months ago

GTHP
0.00%

Performance Overview

Return	GTHP	S&P 500 (^GSPC)
YTD	-6.67%	+1.51%
1-Year	+40.00%	+13.00%
3-Year	-70.83%	+45.32%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Guided Therapeutics, Inc. (GTHP)

Guided Therapeutics Receives $100,000 from SMI’s Investment Partners to Continue Commercialization Process of LuViva in China

Guided Therapeutics Receives Order and Full Payment From Indonesia for 4 LuViva Systems and 1,200 Disposables

Guided Therapeutics Announces Filing of Application for NMPA Approval to Market and Sell LuViva in China

Guided Therapeutics’ Announces Data from Chinese NMPA Clinical Study Signed Off by All Four Clinical Sites With Better Than Expected Results

Performance Overview